Suzanne V. Arnold, MD, MHA; Zhuokai Li, PhD; Sreekanth Vemulapalli, MD; et al.
free access
has audio
JAMA Cardiol. 2018;3(12):1151-1159. doi:10.1001/jamacardio.2018.3359
This cohort study uses data from the Transcatheter Valve Therapy Registry to examine health outcomes among patients undergoing transcatheter mitral valve repair for mitral regurgitation.
-
Podcast:
Association of Quality of Life Outcomes With Transcatheter Mitral Valve Repair
Daniel Lindholm, MD, PhD; Stefan K. James, MD, PhD; Katja Gabrysch, PhD; et al.
free access
JAMA Cardiol. 2018;3(12):1160-1166. doi:10.1001/jamacardio.2018.3811
This secondary analysis of a randomized clinical trial assesses if different biomarkers provide information about the risk for all-cause and cause-specific mortality after acute coronary syndrome.
-
Editorial
Moving the Needle Toward a More Personalized Means of Patient Care
Hanna K. Gaggin, MD, MPH; James L. Januzzi Jr, MD
JAMA Cardiol
Aya J. Alame, BA; Sonia Garg, MD; Julia Kozlitina, PhD; et al.
free access
JAMA Cardiol. 2018;3(12):1167-1173. doi:10.1001/jamacardio.2018.3804
This cohort study determines whether proportion of genetically determined African ancestry is associated with increased electrocardiographic voltage and concentric LV hypertrophy in black compared with white individuals.
Utibe R. Essien, MD, MPH; DaJuanicia N. Holmes, MS; Larry R. Jackson II, MD; et al.
free access
has audio
JAMA Cardiol. 2018;3(12):1174-1182. doi:10.1001/jamacardio.2018.3945
This cohort study uses data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II to assess racial/ethnic differences in the use of oral anticoagulants by patients with atrial fibrillation.
-
Podcast:
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation
-
Editor's Note
Cardiovascular Disease Disparities: The Gap Remains
Clyde W. Yancy, MD, MSc
JAMA Cardiol
Filomena de Nigris, PhD; Francesco Cacciatore, MD, PhD; Francesco P. Mancini, MD, PhD; et al.
free access
JAMA Cardiol. 2018;3(12):1184-1191. doi:10.1001/jamacardio.2018.3546
This autopsy study tests whether epigenetic signatures characterize early fetal atherogenesis associated with maternal hypercholesterolemia and provides a quantitative estimate of the contribution of maternal cholesterol level to fetal lesion size.
Ann Marie Navar, MD, PhD; Tracy Y. Wang, MD, MHS, MSc; Xiaojuan Mi, PhD; et al.
free access
JAMA Cardiol. 2018;3(12):1192-1199. doi:10.1001/jamacardio.2018.3680
This randomized survey study explores how communication tools and presentation formats influence the perception of the severity of atherosclerotic cardiovascular disease risk as well as the potential willingness to take medication therapy among patients in the Patient and Provider Assessment of Lipid Management Registry.